The antifibrotic agent pirfenidone inhibits angiotensin II-induced cardiac hypertrophy in mice
スポンサーリンク
概要
- 論文の詳細を見る
- 2012-01-01
著者
-
ITO Hiroshi
Sakurabashi Watanabe Hospital
-
Inoue Hiroko
Division Of Cardiology Sakurabashi Watanabe Hospital
-
Iwao H
Department Of Pharmacology Osaka City University Medical School
-
Shimada Kenei
Osaka Ekisaikai Hospital
-
Shimada Kenei
Department Of Internal Medicine And Cardiology Osaka City University School Of Medicine
-
Shimada Kenei
Department Of Cardiology Osaka City General Hospital
-
Shimada Kenei
ベルランド総合病院 循環器内科
-
Iwao Hiroshi
Sakurabashi Watanabe Hospital
-
Inanami Hitoshi
大阪掖済会病院 循環器
-
Yoshiyama Minoru
大阪市立総合医療センター 循環器内科
-
Kim-mitsuyama Shokei
熊本大学 医学教育部生体機能薬理学
-
Kim-mitsuyama Shokei
大阪市立大学 医学研究科薬理学
-
Iwao Hiroshi
大阪市立大学 医学部薬効安全性学
-
Shimada Kenei
Department Of Medicine Cardiovascular Division Osaka Ekisaikai Hospital
-
Shimada Kenei
Department Of Cardivascular Medicine Osaka Ekisaikai Hospital
-
Yoshiyama Minoru
大阪市立大学 医学部薬理学
-
Shimeno Kenji
Department Of Internal Medicine And Cardiology Osaka City University Graduate School Of Medicine
-
SHIRATORI KENICHI
Departent of Cardiology Kobe General Hospital
-
Yoshiyama Minoru
Department Of Internal Medicine And Cardiology Osaka City University Graduate School Of Medicine
-
Muro Takashi
Actmce1
-
Teragaki Masakazu
大阪市立大学 医学部内科学第1
-
Masakazu Teragaki
大阪市立大学 第1内科
-
Hirasawa Akira
京都大学 薬学研究科ゲノム創薬科学
-
Shimada Ken-ei
Departments Of Internal Medicine And Cardiology Osaka City University Graduate School Of Medicine
-
IZUMI Yasukatsu
Department of Pharmacology, Osaka City University Medical School
-
SHIOTA Masayuki
Department of Pharmacology, Osaka City University Medical School
-
Ishii Hideshi
大阪市立大学 循環器病態内科学
-
Sakata Konomi
Actmce1
-
Hanatai Akihisa
First Department Of Internal Medicine Osaka City Unitersity Medical School
-
Kim Shokei
大阪市立大学 医学部循環器病態内科学
-
Nakamura Yasuhiro
Department Of Internal Medicine And Cardiology Osaka City University Medical School
-
Murata Takashi
Department Of Internal Medicine Iii Osaka Medical College
-
Shiratori Kenichi
Juntendo University Shizuoka Hospital
-
Morino Yoshihiro
Division Of Cardiovascular Medicine Stanford University School Of Medicine
-
Morino Yoshihiro
Stanford Univ:itabashi Chuo Medical Center
-
Shiota Masayuki
Department Of Pharmacology Osaka City University Medical School
-
Yamazaki Takanori
Department Of Biomolecular Engineering Tokyo Institute Of Technology
-
Iida Hidetaka
Department Of Radiology Graduate School Of Medicine Chiba University
-
Izumi Yasukatsu
Department Of Pharmacology Osaka City University Graduate School Of Medicine
-
Izumi Yuko
Department Of Pharmacology Osaka City University Medical School
-
Hanatani Akihisa
Department Of Cardiovascular Medicine National Cerebral And Cardiovascular Center
-
Itou Hisao
Department Of Radiology School Of Medicine Chiba University
-
Yamashita Naoto
Department Of Internal Medicine Shobara Red Cross Hospital
-
Nakamura Yasuhiro
Department Cardiology Baba Memorial Hospital
-
Iwao Hiroshi
Department Of Pharmacology Osaka City University Graduate School Of Medical Science
-
Shimamura Kunihiro
Department Of Cardiovascular Medicine Wakayama Medical University
-
Yoshiyama Minoru
Department Of Cardiology And Internal Medicine Medical School Osaka City University
-
Morino Yosihiro
Division Of Cardiovascular Medicine Stanford University Medical Center
-
Hanatani Akihisa
Department Of Internal Medicine And Cardiology Osaka City University Graduate School Of Medicine
-
Muro Takashi
Department Of Cardiology And Internal Medicine Medical School Osaka City University
-
Iwao Hiroshi
Department Of Cardiovascular Medicine Akita University Graduate School Of Medicine
-
Yamashita Naoto
Department Of Pharmacology Osaka City University Medical School
-
Morino Yoshihiro
Center For Research In Cardiovascular Interventions Stanford University Medical Center
-
Muro Takashi
Department of Internal Medicine and Cardiology, Osaka City University Medical School
-
YAMAZAKI Takanori
Department of Internal Medicine and Cardiology, Osaka City University Medical School
-
YOSHIYAMA Minoru
Department Internal Medicine and Cardiology, Osaka City University School of Medicine
-
HANATANI Akihisa
Department of Cardiology, Osaka City University School of Medicine
関連論文
- Impact of Diabetes Mellitus on Rehospitalization for Heart Failure Among Survivors of Acute Myocardial Infarction in the Percutaneous Coronary Intervention Era
- 2 Biomarkers, Single Nucleotide Polymorphisms and Cardiovascular Risk after Acute Myocardial Infarction : Observations from the Osaka Acute Coronary Insufficiency Study (OACIS)(Biomarkers, Genetic Polymorphism, and Risk Estimation,Symposium 1 (SY-01) (H),
- 1 Three-Year Outcome of the PRospective Evaluation of VENtricular Tachyarrhythmic Events and Sudden Cardiac Death in Patients with Left Ventricular Dysfunction (PREVENT-SCD) Study(Late Breaking Clinical Trials I,The 73rd Annual Scientific Meeting of The J
- 5 Interim analyses of PRospective Evaluation of VENtricular Tachyarrhythmic events and Sudden Cardiac Death in patients with left ventricular dysfunction (PREVENT-SCD) study(Late Breaking Clinical Trials II,Special Program,The 72nd Annual Scientific Meeti
- Nicorandil Treatment in Patients With Acute Myocardial Infarction : A Meta-Analysis
- PJ-801 Assessment of Myocardial Viability after Acute Myocardial Infarction. By Automated Analysis of Longitudinal Peak Strain at Early Low-dose Dobutamine Stress Echocardiography(PJ134,Echo/Doppler (Peripheral/Vascular) (I),Poster Session (Japanese),The
- PJ-698 Reverse Remodeling of Left Atrium after Pulmonary Vein Isolation for Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy(PJ117,Arrhythmia, Others (Clinical/Diagnosis/Treatment) 5 (A),Poster Session (Japanese),The 73rd Annual Scientific
- PJ-694 Immediate Re-connection of Isolated Pulmonary Vein Potential in Catheter Ablation against Atrial Fibrillation : Its Incidence and Influence on Clinical Result(PJ117,Arrhythmia, Others (Clinical/Diagnosis/Treatment) 5 (A),Poster Session (Japanese),T
- PJ-314 Pioglitazone Treatment Improves Left Ventricular Diastolic Function by Reducing Epicardial Fat in Patients with Type 2 Diabetes Mellitus(PJ053,Metabolic Syndrome 2 (H),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanese Cir
- PJ-296 Increased Left Ventricular Filling Pressure is a New Risk Factor for Left Atrial Thrombus in Patients with Atrial Fibrillation(PJ050,Arrhythmia, Others (Clinical/Diagnosis/Treatment) 4 (A),Poster Session (Japanese),The 73rd Annual Scientific Meetin